Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D05KOP
|
|||
Former ID |
DNCL003238
|
|||
Drug Name |
Ii-Key hybrid peptide vaccine
|
|||
Indication | Influenza A virus H1N1 infection [ICD-11: 1E30] | Phase 1 | [1] | |
Company |
Antigen Express
|
References | Top | |||
---|---|---|---|---|
REF 1 | Results from a phase I clinical study of the novel Ii-Key/HER-2/neu(776-790) hybrid peptide vaccine in patients with prostate cancer. Clin Cancer Res. 2010 Jul 1;16(13):3495-506. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.